Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF ‐1α‐Modulated YAP Pathway Under Hypoxic Conditions
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70111 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Ping Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, People's Hospital of Chongqing Banan District, Chongqing, China. Hauptthemen laut MEDLINE: Apigenin, Hypoxia-Inducible Factor 1, alpha Subunit, Glycolysis, Leukemia, Myeloid, Acute. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Medical Project of the Science and Technology Bureau & the Health Commission of Banan District, Chongqing.
Abstract (Originalsprache)
Vitexin, an apigenin flavone glycoside, exhibits antitumor activity against various cancers including leukemia. Hypoxia enhances glycolysis, thereby promoting tumor growth. In this study, we aimed to explore the effects of vitexin on hypoxia‐induced growth and glycolysis in acute myeloid leukemia (AML) cells and determine the underlying molecular mechanisms. Our findings showed that vitexin inhibited the hypoxia‐induced increase in viability and proliferation of AML cells. Vitexin suppressed glucose uptake, lactate production, and the expression of hexokinase 2, pyruvate kinase M2, and lactate dehydrogenase A in hypoxia‐exposed AML cells. Vitexin also blocked the hypoxia‐induced increase in hypoxia‐inducible factor 1α (HIF‐1α) and Yes‐associated protein (YAP) expression, as well as the decrease in p‐YAP expression. In addition, our results demonstrate that the YAP pathway is regulated by HIF‐1α in hypoxia‐exposed AML cells and participates in the inhibitory effects of vitexin on hypoxia‐induced AML cell growth and glycolysis. These results indicate that vitexin prevents hypoxia‐induced growth and glycolysis in AML cells by regulating the HIF‐1α/YAP signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematopathology, People's Hospital of Chongqing Banan District, Chongqing, China.
- Clinical Laboratory, People's Hospital of Chongqing Banan District, Chongqing, China.
- Department of Traditional Chinese Medicine, The First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
- Department of Respiratory Medicine, The First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
- Department of Endocrinology, The First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
ORCID-Profile: Jia-Jia Zhang
Förderung
- Joint Medical Project of the Science and Technology Bureau & the Health Commission of Banan District, Chongqing
Zitieren
APA
Wang, P., Zhang, J. J., Zhang, F., Qu, X. J., & Zhang, H. (2025). Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF ‐1α‐Modulated YAP Pathway Under Hypoxic Conditions. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70111
Vancouver
Wang P, Zhang JJ, Zhang F, Qu XJ, Zhang H. Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF ‐1α‐Modulated YAP Pathway Under Hypoxic Conditions. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70111
BibTeX
@article{Wang2025,
author = {Wang, Ping and Zhang, Jia-Jia and Zhang, Fang and Qu, Xiao-Jie and Zhang, Hui},
title = {Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF ‐1α‐Modulated YAP Pathway Under Hypoxic Conditions},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70111}
}
EUVIMED